Chapel Hill, NC, United States of America

Raul R Gainetdinov

This inventor holds 7 USPTO granted patents and 3 published patent applications. Top assignees: Duke University, Universidade Federal De Minas Gerais. Active years: 2009-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Raul R Gainetdinov. Retrieved from https://idiyas.com/inventor/raul-r-gainetdinov

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 7 (Patent Applications = 3)

% Patents Active = 42.9

Average Co-Inventor Count = 5.2

ph-index = 1

Forward Citations = 3(Granted Patents)

Company Filing History:

Universidade Federal De Minas Gerais

patents

where one patent can have more than one assignee

Years Active: 2009-2017

Loading Chart...

7 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9585850 - Methods of treatment using arylcyclopropylamine compounds (2017-03-07),

2. 9139638 - Mouse model of cholinergic dysfunction to evaluate cognitive enhancers and drugs that improve myasthenia (2015-09-22),

3. 8877802 - Antiparkinsonian action of phenylisopropylamines (2014-11-04),

4. 8124831 - Transgenic mice carrying functional single nucleotide polymorphisms in brain-specific tryptophan hydroxylase (2012-02-28),

5. 7999075 - Methods for identifying compounds that regulate beta-arrestin signaling complexes (2011-08-16),

6. 7763437 - Methods for identifying compounds that regulate β-Arrestin signaling complexes (2010-07-27),

7. 7585627 - Polymorphism in tryptophan hydroxylase-2 controls brain serotonin synthesis (2009-09-08),

Title: Innovations and Contributions of Raul R Gainetdinov

Introduction

Raul R Gainetdinov is a prominent inventor based in Chapel Hill, NC, known for his significant contributions to the field of neuroscience. He holds a total of seven patents, showcasing his innovative approaches to treating neurological disorders.

Latest Patents

One of his latest patents is focused on methods of treatment using arylcyclopropylamine compounds. This invention is directed towards a method of treating Parkinson's disease using these specific compounds. The arylcyclopropylamine compounds have a defined formula, which is crucial for their therapeutic application. Another notable patent involves a mouse model of cholinergic dysfunction to evaluate cognitive enhancers and drugs that improve myasthenia. This patent describes recombinant non-human mammals with reduced or no expression of vesicular acetylcholine transporter protein (VAChT), which can be used to assess cognitive performance and neuromuscular function.

Career Highlights

Throughout his career, Raul R Gainetdinov has worked with esteemed institutions such as Duke University and Universidade Federal De Minas Gerais. His research has significantly advanced the understanding of cholinergic neurotransmission and its disorders.

Collaborations

He has collaborated with notable colleagues, including Marc G Caron and Martin Beaulieu, contributing to various research projects that aim to enhance the understanding of neurological conditions.

Conclusion

Raul R Gainetdinov's innovative work and patents have made a substantial impact in the field of neuroscience, particularly in the treatment of neurological disorders. His contributions continue to influence research and development in this critical area of medicine.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

3 patents pending: